VNDA trade ideas
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of NighttiVNDA: Vanda Pharmaceuticals Inc.
2020-12-01 18:22:00
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
VNDA - rally until 19.8VNDA seems to be working on a small correction before going up to major resistance at 19.8m. Possible buy areas are indicated in green.
Vanda Pharmaceuticals Receives FDA Approval to Proceed with InveVNDA: Vanda Pharmaceuticals Inc.
2020-10-26 16:01:00
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
Vanda Pharmaceuticals! Earnings 40% Trade!!FA:
Earings release- the last earnings where the estimate was higher than 0.05 per share it led to the stock rallying by 40%- unless, the earings surprise is a negative one; we can expect a rally from Vanda Pharmaceuticals.
TA:
Currently been trading in a limited channel- lack of momentum could lead to a dump if earnings estimate is negative or perhaps mean no rally even if the earnings estimate is positive.
Watch out for the resistance, it is unlikely to take it out in these market conditions.
-Megalodon Whales (Rahim)
Enjoyed Charting this for you all,Please SHARE/LIKE/COMMENT and you are welcome to give your feedback or post your own charts below :)
NASDAQ:VNDA FWB:VM4
VNDA ParabolicParabolic uptrend. Bullish W formation, upsides expected if the uptrend holds. MACD can be seen to be climbing into bullish territory.
Vanda Announces Positive Phase II Study Results for Tradipitant VNDA: Vanda Pharmaceuticals Inc.
2018-12-03 06:00:00
Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis
VNDA Descending ChannelVNDA could be moving in a descending channel before going north again. At this moment is in the upper trendline of the channel.
KL: 16.15
SL: 16.75
TP1: 15.30
TP2: 14.60
VNDA Descending Triangle Pattern. Short (and Long) Opportunity.Simple probability set up. Triangle downtrend started in 11/2016 and VNDA has only been through one full harmonic trend (wave) ever since. Second wave downward move imminent with RSI confirmation @ 35 and bearish $13 target.
However, aggressive long entry for quick profit ($15 bullish target) especially with upcoming earnings. Upon $15 target, (expected RSI >50) short for mid-term trend follow.
Quick Long Target: $15
First Short Target: $13
Second Short Target: $11.50
Total trade should complete by/in April.
VNDA PHARMACEUTICALS RETRACING BEFORE A NEW WAVE UP?VNDA PHARMACEUTICALS is spiking driven by a news event but now it seems going for a correction. If the rising trendline holds i'm expecting a new wave up when this correction is completed.
